Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.

Show other versions (1)

The present study has evaluated the protection conferred by a single subcutaneous dose of a modified vaccinia virus Ankara (MVA) vectored vaccine encoding the Rift Valley Fever virus (RVFV) glycoproteins Gn and Gc in lambs. Three groups of six to seven lambs were immunized as follows: one group rece...

Bibliografske podrobnosti
Main Authors:	Busquets, N, Lorenzo, G, López-Gil, E, Rivas, R, Solanes, D, Galindo-Cardiel, I, Abad, F, Rodríguez, F, Bensaid, A, Warimwe, G, Gilbert, S, Domingo, M, Brun, A
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2014

Podobne knjige/članki

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
od: Busquets, N, et al.
Izdano: (2014)

Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
od: Busquets, N, et al.
Izdano: (2011)

Rift Valley fever: biology and epidemiology
od: Wright, D, et al.
Izdano: (2019)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
od: Warimwe, G, et al.
Izdano: (2013)

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
od: Elena López-Gil, et al.
Izdano: (2020-02-01)

Reproducing the Rift Valley fever virus mosquito-lamb-mosquito transmission cycle
od: Paul J. Wichgers Schreur, et al.
Izdano: (2021-01-01)

Quantifying Rift Valley fever virus transmission efficiency in a lamb-mosquito-lamb model
od: Gebbiena M. Bron, et al.
Izdano: (2023-12-01)

Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley Fever
od: Warimwe, G, et al.
Izdano: (2016)

Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination
od: Gema Lorenzo, et al.
Izdano: (2018-02-01)

Transmission of Rift Valley fever virus from European-breed lambs to Culex pipiens mosquitoes.
od: Rianka P M Vloet, et al.
Izdano: (2017-12-01)

The Pathogenesis of Rift Valley Fever
od: Tetsuro Ikegami, et al.
Izdano: (2011-05-01)

Rift Valley Fever Encephalitis
od: Abdulrahman A. Alrajhi, et al.
Izdano: (2004-03-01)

Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.
od: Zacchaeus Anywaine, et al.
Izdano: (2022-03-01)

New Vectors of Rift Valley Fever in West Africa
od: D. Fontenille, et al.
Izdano: (1998-06-01)

Rift Valley Fever in Goats, Cameroon
od: Matthew LeBreton, et al.
Izdano: (2006-04-01)

Co-housing of Rift Valley fever virus infected lambs with immunocompetent or immunosuppressed lambs does not result in virus transmission
od: Paul J Wichgers Schreur, et al.
Izdano: (2016-03-01)

Seroepidemiology of Rift Valley Fever in Basrah
od: Rahman Kadhum Muhsen
Izdano: (2012-12-01)

An epidemiological model of Rift Valley fever
od: Nicole P. Leahy, et al.
Izdano: (2007-08-01)

Rift Valley fever: the Nigerian story
od: Adewale A. Adeyeye, et al.
Izdano: (2011-01-01)

Rift Valley fever: a review
od: Petrus Jansen van Vuren, et al.
Izdano: (2020-01-01)

Scientific Opinion on Rift Valley fever
od: EFSA Panel on Animal Health and Welfare (AHAW)
Izdano: (2013-04-01)

Drivers of Rift Valley fever epidemics, Madagascar
od: Lancelot, R, et al.
Izdano: (2017)

The Risk of Nosocomial Transmission of Rift Valley Fever.
od: Nasser A Al-Hamdan, et al.
Izdano: (2015-12-01)

Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
od: Clark, M, et al.
Izdano: (2018)

An Overview of Rift Valley Fever Vaccine Development Strategies
od: Paul Kato Kitandwe, et al.
Izdano: (2022-10-01)

A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.
od: Nadia Oreshkova, et al.
Izdano: (2013-01-01)

Rift Valley Fever Epizootic, Rwanda, 2022
od: Eric Remera, et al.
Izdano: (2024-10-01)

Outbreak of Rift Valley Fever in Mauritania, 2022
od: Nounengulie Kire, et al.
Izdano: (2023-11-01)

Molecular Epidemiology and Emergence of Rift Valley Fever
od: Sall AA, et al.
Izdano: (1998-01-01)

An assembly model of Rift Valley fever virus
od: Mirabela eRusu, et al.
Izdano: (2012-07-01)

The 2007 Rift Valley fever outbreak in Sudan.
od: Osama Ahmed Hassan, et al.
Izdano: (2011-09-01)

Rift Valley Fever, Sudan, 2007 and 2010
od: Imadeldin E. Aradaib, et al.
Izdano: (2013-02-01)

Rift Valley Fever Potential, Arabian Peninsula
od: Assaf Anyamba, et al.
Izdano: (2006-03-01)

Reemergence of Rift Valley Fever, Mauritania, 2010
od: Ousmane Faye, et al.
Izdano: (2014-02-01)

Rift Valley Fever, Mayotte, 2007–2008
od: Daouda Sissoko, et al.
Izdano: (2009-04-01)

Rift Valley fever and Brucella spp. in ruminants, Somalia
od: Ahmed A. Hassan-Kadle, et al.
Izdano: (2021-08-01)

Field-captured Aedes vexans (Meigen, 1830) is a competent vector for Rift Valley fever phlebovirus in Europe
od: Lotty Birnberg, et al.
Izdano: (2019-10-01)

Unique Outbreak of Rift Valley Fever in Sudan, 2019
od: Ayman Ahmed, et al.
Izdano: (2020-12-01)

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
od: Stedman, A, et al.
Izdano: (2019)

Alteration in the Culex pipiens transcriptome reveals diverse mechanisms of the mosquito immune system implicated upon Rift Valley fever phlebovirus exposure.
od: Ana I Núñez, et al.
Izdano: (2020-12-01)